Clene Price To Sales Ratio from 2010 to 2024

CLNN Stock  USD 4.17  0.16  3.99%   
Clene Price To Sales Ratio yearly trend continues to be very stable with very little volatility. Price To Sales Ratio is likely to drop to 45.20. Price To Sales Ratio is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing Clene's market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
47.5754742
Current Value
45.2
Quarterly Volatility
1.3 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Clene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clene's main balance sheet or income statement drivers, such as Interest Expense of 4.8 M, Tax Provision of 0.0 or Depreciation And Amortization of 1.5 M, as well as many indicators such as Price To Sales Ratio of 45.2, Dividend Yield of 0.0 or PTB Ratio of 2.21. Clene financial statements analysis is a perfect complement when working with Clene Valuation or Volatility modules.
  
Check out the analysis of Clene Correlation against competitors.

Latest Clene's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Clene Inc over the last few years. Price to Sales Ratio is figured by comparing Clene Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Clene sales, a figure that is much harder to manipulate than other Clene Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period. Clene's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Clene's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 75.28 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Clene Price To Sales Ratio Regression Statistics

Arithmetic Mean2,284
Geometric Mean1,232
Coefficient Of Variation58.53
Mean Deviation1,141
Median3,062
Standard Deviation1,337
Sample Variance1.8M
Range3K
R-Value(0.77)
Mean Square Error775,749
R-Squared0.60
Significance0.0007
Slope(231.02)
Total Sum of Squares25M

Clene Price To Sales Ratio History

2024 45.2
2023 47.58
2022 137.85
2021 349.09

About Clene Financial Statements

Clene investors utilize fundamental indicators, such as Price To Sales Ratio, to predict how Clene Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Price To Sales Ratio 47.58  45.20 

Pair Trading with Clene

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Clene position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clene will appreciate offsetting losses from the drop in the long position's value.

Moving against Clene Stock

  0.51VCYT VeracytePairCorr
  0.49VERA Vera TherapeuticsPairCorr
  0.31VCEL Vericel Corp OrdPairCorr
The ability to find closely correlated positions to Clene could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Clene when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Clene - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Clene Inc to buy it.
The correlation of Clene is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Clene moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Clene Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Clene can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Clene Inc is a strong investment it is important to analyze Clene's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Clene's future performance. For an informed investment choice regarding Clene Stock, refer to the following important reports:
Check out the analysis of Clene Correlation against competitors.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.614
Earnings Share
(5.29)
Revenue Per Share
0.069
Quarterly Revenue Growth
(0.66)
Return On Assets
(0.42)
The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.